Medvarsity Logo
Management of Pediatric Pneumonia

CASE DISCUSSION

Management of Pediatric Pneumonia

India flagPresented India by Dr. Bharat Parmar

Views

13,991

Case Description

Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high...

Case Summary

  • Childhood pneumonia remains a leading cause of pediatric hospitalization and mortality worldwide, accounting for substantial under-five mortality in developing regions. Etiology varies fundamentally by age, environment, and host immune status. Community-acquired cases are predominantly viral, driven by respiratory syncytial virus, influenza, and adenovirus, followed by bacterial pathogens. In neonates, enteric gram-negative bacilli, group B Streptococcus, and Staphylococcus aureus predominate. In infants and preschool children, Streptococcus pneumoniae and Haemophilus influenzae are primary pathogens, whereas Mycoplasma pneumoniae and Chlamydia species become prominent in school-aged children and adolescents. Nosocomial and opportunistic presentations are dominated by Klebsiella, Pseudomonas aeruginosa, Staphylococcus aureus, and Pneumocystis jirovecii in immunocompromised hosts.

Speaker Profile

Dr. Bharat Parmar

Dr. Bharat Parmar

Professor And Head of Pediatrics at Zydus Medical College, Civil Hospital
Dr. Bharat Parmar is a distinguished pediatrician and academician with extensive expertise in child healthcare, pediatric education, and clinical pediatrics. He serves as the Professor and Head of the Department of Pediatrics at Zydus Medical College and Civil Hospital. Dr. Parmar is known for his contributions to pediatric care, medical teaching, and advancing evidence-based practices in child health and neonatal care.

Disclosures

Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.